Table 3. Results of the latencies of the components of evoked fields that were significantly different between patients with Parkinson’s disease and healthy control participants.

	Patients		Controls			p
	Average	± SD		Average	± SD
VEF1 N75m
L	86.7	± 8.3		80.0	± 3.6		0.005
R	88.2	± 9.6		81.3	± 2.6		0.007
S4	86.7	± 8.3		80.6	± 2.4		0.006
M5	88.1	± 9.6		80.6	± 2.4		0.003
VEF P100m
L	124.1	± 17.7		111.9	± 12.1		0.037
VEF N145m
L	179.3	± 20.2		165.3	± 12.5		0.028
AEF2 P50m
Rc6	56.7	± 6.3		52.3	± 3.1		0.015
Li7	67.2	± 9.2		59.8	± 5.3		0.009
Si	64.5	± 9.3		57.9	± 4.6		0.015
Mi	64.7	± 11.9		57.9	± 4.6		0.040
AEF P100m
Rc	100.2	± 12.5		90.9	± 6.7		0.012
Sc	99.2	± 13.8		91.0	± 5.3		0.027
Mc	99.8	± 13.8		91.0	± 5.3		0.019
Li	113.3	± 13.2		101.1	± 6.2		0.002
Ri	108.0	± 12.9		99.4	± 6.2		0.020
Si	109.4	± 13.6		100.2	± 4.7		0.012
Mi	111.8	± 12.9		100.2	± 4.7		0.001
AEF P100m - P50m
Mc	43.9	± 8.9		38.0	± 5.1		0.029
SEF3 P60m
L	67.0	± 12.7		53.4	± 13.0		0.01
R	67.1	± 12.0		48.1	± 9.2		<0.01*
S	63.6	± 12.3		50.8	± 9.3		<0.01
M	70.5	± 11.3		50.8	± 9.3		<0.01*
SEF P60m - N20m
L	43.5	± 11.6		30.7	± 12.5		0.014
R	43.9	± 11.8		25.7	± 8.9		<0.001*
S	40.4	± 11.9		28.2	± 9.1		0.005
M	47.0	± 10.5		26.9	± 8.5		<0.001*
SEF P60m - P35m
L	36.8	± 12.4		23.5	± 12.8		0.014
R	36.7	± 11.9		18.7	± 8.9		<0.001*
S	33.3	± 11.8		21.1	± 9.2		0.005
M	40.2	± 11.4		19.9	± 8.5		<0.001*

Latencies are reported in ms.

*: Significant after Bonferroni correction. Abbreviations

¹VEF: visual evoked magnetic field

²AEF: auditory evoked magnetic field

³SEF: somatosensory evoked magnetic field

⁴S: severe side stimulation

⁵M: mild side stimulation

⁶c: contralateral side recording

⁷i: ipsilateral side recording.